ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0305

Inflammatory T Cell Expansion in Yao Syndrome

Danielle Xie1, Rimanpreet Kaur2, Richard Kew2, Qingping Yao3 and Charles Vorkas2, 1Stony Brook University, East Setauket, 2Stony Brook University, Stony Brook, 3Stony Brook University, Stony Brook, NY

Meeting: ACR Convergence 2024

Keywords: Autoinflammatory diseases, immunology, Inflammation, innate immunity, T-Lymphocyte

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Yao syndrome (YAOS, #OMIM 617321), formerly known as nucleotide-binding oligomerization protein containing 2 (NOD2)-associated autoinflammatory disease, is associated with specific NOD2 mutations and affects multiple organ systems. NOD2 is an intracellular immune sensor of bacterial peptidoglycan and is critical for innate responses to infections. Mechanistic study of immune dysfunction in YAOS is very limited, but the diverse clinical manifestations are hypothesized to be driven by aberrant NOD2 signaling in innate immune cells, such as monocytes. This study aimed to define immune cell subset frequency and function in blood of YAOS patients compared to healthy controls to identify targets for novel therapeutics.

Methods: Ten adult YAOS study volunteers of European ancestry were enrolled (n=10, 80% female, mean age 36±12 at diagnosis). These patients were identified to carry NOD2 mutations by an autoinflammatory disease gene panel and exhibited a clinical phenotype consistent with YAOS. Nine healthy adult volunteers were recruited as controls (n=9, 30% female, mean age 42±16). Flow cytometric analysis of peripheral blood immune cell populations were assessed at baseline and after 16 hours of stimulation with the bacterial cell wall-derived NOD2 ligand, muramyl dipeptide (MDP), Toll-like receptor ligands (TLRLs; LPS, Pam2Cys, PolyIC), and antibodies against CD3/CD28 (αCD3/CD28) for non-specific T cell stimulation.

Results: YAOS cases exhibited higher frequency of CD3+ cells (64% vs. 49%; p=0.034) compared to healthy controls with similar proportions of CD4+ and CD8+ T cells in both groups. In the CD3 negative compartment, monocytes were depleted in YAOS compared to healthy controls (18% vs. 29%; p=0.032). No significant differences were observed in the frequencies of B, Natural Killer (NK), γδ T, and MAIT cells. Following αCD3/CD28 stimulation in vitro, YAOS cases demonstrated increased interferon γ – expressing CD4+ T (5% vs. 1%; p=0.00017), MAIT (20% vs. 10%; p=0.047), and γδ T cells (8% vs. 1%; p=0.0021). Monocytes and NK cells from patients had relatively depressed responses to MDP compared to controls, though these differences did not reach statistical significance. Immune response to TLRLs  did not differ between groups.

Conclusion: Our study shows significant alterations in innate and adaptive immunity in YAOS patients evidenced by monocyte depletion and expansion of inflammatory CD4+ T, MAIT, and γδ T cells. These novel findings suggest that the disease immunopathology may be driven by antigen-independent bystander T cell activation in addition to innate cellular dysfunction. Future studies will elucidate the underlying mechanisms of this immune dysregulation, which could inform targeted therapeutic strategies.


Disclosures: D. Xie: None; R. Kaur: None; R. Kew: None; Q. Yao: None; C. Vorkas: None.

To cite this abstract in AMA style:

Xie D, Kaur R, Kew R, Yao Q, Vorkas C. Inflammatory T Cell Expansion in Yao Syndrome [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/inflammatory-t-cell-expansion-in-yao-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inflammatory-t-cell-expansion-in-yao-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology